Anxiety and depression in patients with pulmonary hypertension: impact and management challenges

Maurizio Bussotti,1 Marinella Sommaruga2 1Cardiorespiratory Rehabilitation Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Scientific Institute of Milan, Milan, Italy; 2Psychology Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Scientific Institute of Milan, Milan, Italy Background: Anxiety an...

Full description

Bibliographic Details
Main Authors: Bussotti M, Sommaruga M
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Vascular Health and Risk Management
Subjects:
Online Access:https://www.dovepress.com/anxiety-and-depression-in-patients-with-pulmonary-hypertension-impact--peer-reviewed-article-VHRM
_version_ 1818963446092267520
author Bussotti M
Sommaruga M
author_facet Bussotti M
Sommaruga M
author_sort Bussotti M
collection DOAJ
description Maurizio Bussotti,1 Marinella Sommaruga2 1Cardiorespiratory Rehabilitation Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Scientific Institute of Milan, Milan, Italy; 2Psychology Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Scientific Institute of Milan, Milan, Italy Background: Anxiety and depression are frequent disorders in patients with pulmonary arterial hypertension (PAH), but despite this only less than one-fourth of them is treated. Our aim was to review the studies regarding the prevalence and the impact of anxiety and depression and to propose management challenges. Methods: A literature review regarding 1) anxiety and depression studies in PAH patients and caregivers, 2) psychological interventions, 3) slow breathing approach, and 4) pharmacological approach was performed, based on evidence of effectiveness through a search of the most well-known databases (Cochrane Library, Medline, PsychINFO [2004–2018]). Results: The prevalence of mental disorders in PAH patients lies between 7.5% and 53% for depression and 19% and 51% for anxiety and panic disorders. The latest guidelines of the European Society of Cardiology recommend a psychological support with a class of recommendation I and a level of evidence c. The analysis of psychological intervention shows that at present there is no evidence of specific psychological interventions in these patients. However, treatment approaches based on other chronic illnesses are suggested, especially based on relaxation training, slow breathing, and cognitive behavioral therapy. Finally, data concerning the use of antidepressant drugs are conflicting. Conclusion: Firstly, our data demonstrate a common underestimation of mental disorders by health professionals and secondly, the need of implementing appropriate methods of screening for mental disorders in PAH patients. However, the paucity of large observational studies in this area requires the attention of researchers. The evidence about optimal approaches for managing anxiety and depression in PAH also remains unclear and largely speculative. The challenge is the introduction of routine psychological intervention, as suggested by the European Society of Cardiology and already applied in other chronic disease. Keywords: pulmonary arterial hypertension, anxiety, depression, psychological distress, rehabilitation, psychological intervention
first_indexed 2024-12-20T12:45:21Z
format Article
id doaj.art-2e3b089823fc43cf904b008f7213fafb
institution Directory Open Access Journal
issn 1178-2048
language English
last_indexed 2024-12-20T12:45:21Z
publishDate 2018-11-01
publisher Dove Medical Press
record_format Article
series Vascular Health and Risk Management
spelling doaj.art-2e3b089823fc43cf904b008f7213fafb2022-12-21T19:40:20ZengDove Medical PressVascular Health and Risk Management1178-20482018-11-01Volume 1434936042113Anxiety and depression in patients with pulmonary hypertension: impact and management challengesBussotti MSommaruga MMaurizio Bussotti,1 Marinella Sommaruga2 1Cardiorespiratory Rehabilitation Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Scientific Institute of Milan, Milan, Italy; 2Psychology Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Scientific Institute of Milan, Milan, Italy Background: Anxiety and depression are frequent disorders in patients with pulmonary arterial hypertension (PAH), but despite this only less than one-fourth of them is treated. Our aim was to review the studies regarding the prevalence and the impact of anxiety and depression and to propose management challenges. Methods: A literature review regarding 1) anxiety and depression studies in PAH patients and caregivers, 2) psychological interventions, 3) slow breathing approach, and 4) pharmacological approach was performed, based on evidence of effectiveness through a search of the most well-known databases (Cochrane Library, Medline, PsychINFO [2004–2018]). Results: The prevalence of mental disorders in PAH patients lies between 7.5% and 53% for depression and 19% and 51% for anxiety and panic disorders. The latest guidelines of the European Society of Cardiology recommend a psychological support with a class of recommendation I and a level of evidence c. The analysis of psychological intervention shows that at present there is no evidence of specific psychological interventions in these patients. However, treatment approaches based on other chronic illnesses are suggested, especially based on relaxation training, slow breathing, and cognitive behavioral therapy. Finally, data concerning the use of antidepressant drugs are conflicting. Conclusion: Firstly, our data demonstrate a common underestimation of mental disorders by health professionals and secondly, the need of implementing appropriate methods of screening for mental disorders in PAH patients. However, the paucity of large observational studies in this area requires the attention of researchers. The evidence about optimal approaches for managing anxiety and depression in PAH also remains unclear and largely speculative. The challenge is the introduction of routine psychological intervention, as suggested by the European Society of Cardiology and already applied in other chronic disease. Keywords: pulmonary arterial hypertension, anxiety, depression, psychological distress, rehabilitation, psychological interventionhttps://www.dovepress.com/anxiety-and-depression-in-patients-with-pulmonary-hypertension-impact--peer-reviewed-article-VHRMPulmonary arterial hypertensionanxietydepressionpsychological distressrehabilitation
spellingShingle Bussotti M
Sommaruga M
Anxiety and depression in patients with pulmonary hypertension: impact and management challenges
Vascular Health and Risk Management
Pulmonary arterial hypertension
anxiety
depression
psychological distress
rehabilitation
title Anxiety and depression in patients with pulmonary hypertension: impact and management challenges
title_full Anxiety and depression in patients with pulmonary hypertension: impact and management challenges
title_fullStr Anxiety and depression in patients with pulmonary hypertension: impact and management challenges
title_full_unstemmed Anxiety and depression in patients with pulmonary hypertension: impact and management challenges
title_short Anxiety and depression in patients with pulmonary hypertension: impact and management challenges
title_sort anxiety and depression in patients with pulmonary hypertension impact and management challenges
topic Pulmonary arterial hypertension
anxiety
depression
psychological distress
rehabilitation
url https://www.dovepress.com/anxiety-and-depression-in-patients-with-pulmonary-hypertension-impact--peer-reviewed-article-VHRM
work_keys_str_mv AT bussottim anxietyanddepressioninpatientswithpulmonaryhypertensionimpactandmanagementchallenges
AT sommarugam anxietyanddepressioninpatientswithpulmonaryhypertensionimpactandmanagementchallenges